THERAVANCE BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.39 USD | -1.98% |
|
-1.57% | -16.46% |
| 13/05 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
| 13/05 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Other Pharmaceuticals | -1.98% | -1.57% | -16.46% | -16.90% | -56.06% | 465M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- TBPH Stock
- Charts Theravance Biopharma, Inc.
- Comparison Chart